RadNet, Inc.

NASDAQ:RDNT

Medical - Diagnostics & Research

Healthcare
$71.82 +2.90%

+$1.53 today

Market cap
$5.66B
Beta
1.39
P/E (TTM)
-295.1
EPS (TTM)
-$0.18
52W Low $50.76High $85.84

Volume 0.81M

Average 0.80M

RDNT Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

RadNet, Inc.NASDAQ: RDNT

Financing Cash Flow · Q3 FY2026 · quarter ended Sep 2026

Financing cash flow grows, but more slowly than its trailing trend

Q3 FY2026 financing cash flow of $12.84M (cash outflow) rose 141.6% year over year, behind the +168.4% change in trailing-twelve-month financing cash flow. Over 3 fiscal years it compounded at -8.3% a year.

Context

  • Financing cash flow amounted to 3.5% of revenue in FY2025, down 18.2 pp from a year earlier.
  • Financing cash flow increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +141.6% toward the trailing-twelve-month pace of +168.4%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$12.84M-105.2% QoQ
Last fiscal yearDec 2025
$72.21M-81.9% YoY
LTMSep 2026
$207.97M+168.4% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+141.6%——
1 year-81.9%——
3-year CAGR-8.3%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
72.21M USD
Year-over-year change
-81.9%
4-year CAGR
-8.9%

Financing Cash Flow vs competitors

How RDNT compares with its peers on the latest reported figures

  • RDNT's LTM Sep 2026 financing cash flow of $207.97M is the 2nd largest of the 7 companies compared; the peer median is $12.13M.
  • Its year-over-year change of +168.4% is the 3rd highest of 7, against a peer median of +33.2%.
  • Financing cash flow amounts to 8.7% of revenue for RDNT, versus a peer median of 4.0%.
RDNT Competitors Peer median
Financing Cash Flow for RDNT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$883M -224.0%—4.4%
RDNTRadNet, Inc.LTM Sep 2026$207.97M +168.4%-8.3%8.7%
LMRILumexa Imaging Holdings, Inc. Common StockFY2025$36.58M +392.7%—3.6%
BRKRBruker CorporationLTM Jun 2026$35.1M +205.1%—1.0%
NNOXNano-X Imaging Ltd.LTM Dec 2025$22.66M -42.6%+198.4%174.0%
IRMDIRadimed CorporationLTM Mar 2026$17.93M +109.1%+11.5%20.8%
BFLYButterfly Network, Inc.LTM Mar 2026$1.6M -97.9%+200.0%1.6%
Peer median (excluding RDNT) $12.13M+33.2%+198.4%4.0%

Competitors are the stored peer set for RDNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income44.32M33.61M30.34M38.84M46.77M
Depreciation & Amortization170.66M184.72M189.49M137.84M152.13M
Deferred Income Tax(21.49M)13.36M0010.83M
Stock-Based Compensation25.2M23.77M26.79M29.83M54.6M
Change in Working Capital(92.13M)(58.7M)(40.27M)(56.49M)(9.75M)
Accounts Receivables(5.89M)(30.08M)2.65M(21.77M)(9.56M)
Inventory(87.67M)0000
Accounts Payables9.92M49.78M15.09M37.12M52.42M
Other Working Capital(8.49M)(78.4M)(58.01M)(71.84M)(52.61M)
Other Non-Cash Items22.93M(50.35M)14.52M83M44.24M
Operating Cash Flow149.49M146.42M220.86M233.02M298.82M
Capital Expenditures(220.7M)(249.41M)(176.6M)(188.07M)(213.25M)
Acquisitions (Net)(1.44M)(1.44M)(24.95M)(45.16M)(133.42M)
Purchases of Investments(1.44M)(1.44M)000
Sales of Investments1.44M1.44M000
Other Investing Activities625K3.9M83K157K2.81M
Investing Cash Flow(221.51M)(246.95M)(201.47M)(233.07M)(343.87M)
Debt Repayment94.48M94.25M(43.99M)165.33M71.22M
Common Stock Issued488K294K245.83M218.39M5.45M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities9.71M(893K)(6.2M)14.23M(4.46M)
Financing Cash Flow104.67M93.65M195.64M397.95M72.21M
Effect of Forex Changes(65K)113K(292K)(453K)33K
Net Change in Cash32.59M(6.77M)214.74M397.45M27.2M
Free Cash Flow(71.2M)(103M)44.26M44.95M85.57M

RadNet, Inc.

NASDAQ:RDNT

Intrinsic Alpha fair value

Locked

Current Price

$71.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.